Literature DB >> 15298520

Status of end of life care in organizations providing services for older people with a developmental disability.

Anne L Botsford1.   

Abstract

Volunteers of America conducted a national survey of directors of 500 organizations providing services to older people with an intellectual disability in order to establish a baseline for assessing current status of end of life care. The questionnaire contained 56 questions. The return rate was 32% (N = 160). Data analysis provided an overview of organizational needs, resource allocations, end of life care services currently provided, obstacles to care, methods for monitoring such care, and existing and recommended strategies for improving this care. Results underscored the needs for practical guidelines and resources, increased staffing and training, and policy-level reduction of obstacles to promote improved end of life care.

Entities:  

Mesh:

Year:  2004        PMID: 15298520     DOI: 10.1352/0895-8017(2004)109<421:SOEOLC>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  3 in total

Review 1.  The state of the science of health and wellness for adults with intellectual and developmental disabilities.

Authors:  Lynda Lahti Anderson; Kathy Humphries; Suzanne McDermott; Beth Marks; Jasmina Sisirak; Jasmina Sisarak; Sheryl Larson
Journal:  Intellect Dev Disabil       Date:  2013-10

2.  'From activating towards caring': shifts in care approaches at the end of life of people with intellectual disabilities; a qualitative study of the perspectives of relatives, care-staff and physicians.

Authors:  Nienke Bekkema; Anke J E de Veer; Cees M P M Hertogh; Anneke L Francke
Journal:  BMC Palliat Care       Date:  2015-07-25       Impact factor: 3.234

3.  The palliative care needs of adults with intellectual disabilities and their access to palliative care services: A systematic review.

Authors:  Emily Adam; Katherine E Sleeman; Sarah Brearley; Katherine Hunt; Irene Tuffrey-Wijne
Journal:  Palliat Med       Date:  2020-06-17       Impact factor: 4.762

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.